MiR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma
Related Experiment Video
Updated: Mar 24, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Xiaoying Wang1, Yanli Liu2, Xiaoli Liu3
1Department of Pathology, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China.
Abstract:
Accumulating evidence indicates that dysregulation of microRNAs (miRNAs) may contribute to the initiation and progression of cancer. However, the role of miR-124 in lung adenocarcinoma (ADC) and the underlying mechanisms through which miR-124 exerts its functions are not completely understood. In the present study, we detected miR-124 and SOX9 expression in lung ADC tissues. The results showed that miR-124 was significantly downregulated in the lung ADC tissues compared with that noted in the corresponding non-cancerous lung tissues and the level of SOX9 protein was inversely associated with the expression of miR-124. The study in human lung ADC cell line A549 demonstrated that upregulation of miR-124 could inhibit cell proliferation, migration and invasion. The bioinformatic analysis showed that there was a putative miR-124 binding site in the 3' untranslated region (3'UTR) of SOX9. Using a luciferase reporter assay, we verified that SOX9 is a direct target of miR-124. Furthermore, overexpression of miR-124 repressed SOX9 expression, whereas inhibition of miR-124 increased expression of SOX9 in the A549 cells. Finally, we identified that SOX9 was a functional mediator of miR-124 in A549 cells. Taken together, our results suggest that miR-124 functions as a tumor suppressor in lung ADC by directly targeting SOX9 and it may be a promising candidate for miR‑based therapy against lung ADC.
Insights
MicroRNA-124 (miR-124) acts as a tumor suppressor in lung adenocarcinoma (ADC) by inhibiting cancer cell growth and spread. It directly targets SOX9, suggesting potential for miR-124 based therapies in lung ADC treatment.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNA (miRNA) dysregulation is implicated in cancer development.
- The specific role and mechanism of miR-124 in lung adenocarcinoma (ADC) remain unclear.
Purpose of the Study:
- To investigate the function of miR-124 in lung ADC.
- To elucidate the underlying molecular mechanisms involving SOX9.
Main Methods:
- Quantitative analysis of miR-124 and SOX9 expression in lung ADC tissues and cell lines.
- Cell proliferation, migration, and invasion assays.
- Bioinformatic analysis, luciferase reporter assays, and Western blotting to confirm SOX9 as a direct target of miR-124.
Main Results:
- miR-124 was significantly downregulated in lung ADC tissues.
- miR-124 overexpression inhibited proliferation, migration, and invasion of A549 lung ADC cells.
- SOX9 was identified as a direct target of miR-124, with its expression inversely correlated to miR-124 levels.
Conclusions:
- miR-124 functions as a tumor suppressor in lung ADC by directly targeting SOX9.
- miR-124 may serve as a potential therapeutic target for lung ADC treatment.
More Related Videos
Related Concept Videos
MicroRNAs
MicroRNAs
Cancer Cell Migration through Invadopodia

